What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Mucositis, Chemotherapy, Surgery, Internal medicine and Cancer.
The concepts of his Mucositis study are interwoven with issues in Palifermin, Intensive care medicine, Immunology and Pathology.
His Chemotherapy study combines topics in areas such as Oral mucosa, Cancer research, Pathogenesis, Disease and Cancer therapy.
His Surgery study incorporates themes from Clinical trial and Incidence.
His work deals with themes such as Gastroenterology, Erythema and Oncology, which intersect with Internal medicine.
The concepts of his Cancer study are interwoven with issues in Concomitant, Toxicity and MEDLINE.
His most cited work include:
- Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients (971 citations)
- The pathobiology of mucositis. (742 citations)
- Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis† (623 citations)
What are the main themes of his work throughout his whole career to date?
Stephen T. Sonis mostly deals with Mucositis, Internal medicine, Surgery, Cancer and Chemotherapy.
Stephen T. Sonis combines subjects such as Stomatitis, Head and neck cancer, Immunology and Intensive care medicine with his study of Mucositis.
In the field of Internal medicine, his study on Toxicity overlaps with subjects such as In patient.
His Surgery research is multidisciplinary, relying on both Incidence and Palifermin.
His work carried out in the field of Cancer brings together such families of science as Regimen, Concomitant and MEDLINE.
His Chemotherapy research focuses on subjects like Pathology, which are linked to Cancer research.
He most often published in these fields:
- Mucositis (57.52%)
- Internal medicine (44.63%)
- Surgery (25.78%)
What were the highlights of his more recent work (between 2013-2021)?
- Mucositis (57.52%)
- Internal medicine (44.63%)
- Cancer (24.11%)
In recent papers he was focusing on the following fields of study:
Stephen T. Sonis mainly investigates Mucositis, Internal medicine, Cancer, Oncology and Head and neck cancer.
His Mucositis study necessitates a more in-depth grasp of Radiation therapy.
His Internal medicine research incorporates themes from Gastroenterology and Surgery.
His research in Cancer intersects with topics in Chemotherapy, MEDLINE, Bioinformatics, Regimen and Drug.
His Oncology course of study focuses on Toxicity and Stomatitis.
His Head and neck cancer study combines topics from a wide range of disciplines, such as Clinical trial and Head and neck.
Between 2013 and 2021, his most popular works were:
- MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy (579 citations)
- Mucositis: pathobiology and management (130 citations)
- Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations (86 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Mucositis, Cancer, Internal medicine, Radiation therapy and Surgery are his primary areas of study.
Mucositis is a subfield of Toxicity that he studies.
His research on Cancer also deals with topics like
- Chemotherapy together with Complication,
- Regimen which connect with Immunology.
His studies deal with areas such as Placebo and Oncology as well as Internal medicine.
His studies in Radiation therapy integrate themes in fields like Guideline and MEDLINE.
As part of the same scientific family, Stephen T. Sonis usually focuses on Surgery, concentrating on Pharmacotherapy and intersecting with Hematopoietic stem cell transplantation, Oral mucosa and Oral Microbiome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
